UPDATE 1-Teva gets US okay to buy Cephalon with conditions
October 07, 2011 at 18:00 PM EDT
WASHINGTON, Oct 7 (Reuters) - Teva Pharmaceutical Industries won U.S. antitrust approval to buy specialty drugmaker Cephalon after agreeing to conditions aimed at preserving competition in the market for sleep disorder medicine Provigil and two other drugs.
